findmyKOL
Clinical trialNCT02838316Active, not recruitingPhase 1Interventional

Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR) for Tongue Dysphagia

SponsorPeter Belafsky, MDEnrollment18Oropharyngeal Dysphagia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary objective of this study is to evaluate the safety of Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR) during the 12 months following treatment of tongue dysphagia in male and female patients who have undergone surgery and/or chemo- and/or radiotherapy for squamous cell cancer of the oropharynx.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Maggie Kuhn, MD

    University of California Davis, Department of Otolaryngology

    Principal Investigator
    clinicaltrials.gov ↗
  • Nogah Nativ, PhD

    University of California Davis, Department of Otolaryngology

    Study Director
    clinicaltrials.gov ↗
  • Peter Belafsky, MD, PhD

    University of California Davis, Department of Otolaryngology

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Uc Davis Medical Center, Department of Otolaryngology, Head and Neck Surgery

    Sacramento, California, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Autologous Muscle Derived Cells for Gastro-Intestinal Repair
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
24 May 2017
Primary completion
31 Dec 2026
Completion
31 Dec 2026
Last update posted
20 Apr 2026
Registered enrollment
18
Registry id
NCT02838316
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.